Testing of organisms for susceptibility to triazoles: Is it justified?

European Journal of Clinical Microbiology & Infectious Diseases

Volumn 8, Issue 5, 1989, Pages 387-389

  Kobayashi, G S ^a   Spitzer, E D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE;

ANTIBIOTIC SENSITIVITY; EDITORIAL; FUNGUS; FUNGUS GROWTH; HUMAN; IN VITRO STUDY; LABORATORY TEST; MINIMUM INHIBITORY CONCENTRATION; TURBIDIMETRY;

ANTIFUNGAL AGENTS; DRUG RESISTANCE, MICROBIAL; FLUCONAZOLE; FUNGI; HUMAN; ITRACONAZOLE; KETOCONAZOLE; MICROBIAL SENSITIVITY TESTS; MYCOSES; TRIAZOLES;

EID: 0024315008     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/BF01964051     Document Type: Editorial

References (16)

1. The polyenes
2. Azole antifungal agents: emphasis on new triazoles
3. Biochemical targets for antifungal azole derivatives: hypothesis on the mode of action
4. Heterogeneity of action mechanisms among antimycotic imidazoles
5. Azole resistance in Candida albicans
6. Inhibition of 14 alpha-sterol demethylase activity in Candida albicans Darlington does not correlate with resistance to azole
7. Isolation and analysis of ketoconazole-resistant mutants of Saccharomyces cerevisiae
8. Laboratory tests for the activity of imidazole and triazole antifungal agents in vitro
9. Comparison of relative susceptibilities of Candida species to three antifungal agents as determined by unstandardized methods
10. Multicenter evaluation of four methods of yeast inoculum preparation
11. Collaborative evaluation in seven laboratories of a standardized micromethod for yeast susceptibility testing
12. Antifungal susceptibility tests
13. Broth dilution testing of Candida albicans susceptibility to ketoconazole
14. Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivo
15. Treatment of systemic mycoses with ketoconazole: in vitro susceptibilities of clinical isolates of systemic and pathogenic fungi to ketoconazole